Obstetrical and neonatal outcomes after single and double gamete donation
Article Sidebar
Main Article Content
Abstract
Introduction: An increasing number of women and couples need oocyte donation to help achieve pregnancy. Several studies have found a correlation between the use of oocyte donation and adverse obstetrical outcomes such as gestational hypertension and preeclampsia. A possible additive risk in using double donation (oocyte and sperm donation) compared to the use solely of oocyte donation has been suggested but only sparsely investigated. The aim of this study is to investigate the differences in obstetric and neonatal outcomes after double donation compared to oocyte donation.
Methods: This is a retrospective cohort study of 197 women, who achieved pregnancy after oocyte donation between 2015 and 2022. The primary outcomes investigated were gestational hypertension and preeclampsia. Secondary outcomes were early pregnancy loss, HELLP (Hemolysis, Elevated Liver enzymes, and Low Platelets) syndrome, fetal growth restriction, and gestational diabetes mellitus.
Results: No significant differences between the use of oocyte and double donation were observed, when looking at the risk of developing gestational hypertension (AOR = 1.02, 95%CI = [0.33;3.15], P = 0.97) or preeclampsia (AOR = 2.4, 95%CI = [0.68;8.41], P = 0.17). We observed no significant differences between the two groups regarding any of the secondary outcomes.
Conclusion: This study did not find an increased risk of obstetrical or neonatal complications such as preeclampsia, gestational diabetes mellitus, or fetal growth restriction after double donation compared to oocyte donation.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
CC BY. The paper and it's contents belong to the author, and can be used by others when giving appropriate credit to the authors and the creator (DJOG).
How to Cite
References
Anthony, S., Jacobusse, G. W., van der Pal-de Bruin, K. M., Buitendijk, S. & Zeitlin, J. Do differences in maternal age, parity and multiple births explain variations in fetal and neonatal mortal-ity rates in Europe? - Results from the EURO-PERISTAT project. Paediatr Perinat Epidemiol 23, 292–300 (2009). DOI: https://doi.org/10.1111/j.1365-3016.2009.01044.x
Danmarks statistik: Gennemsnitsalder for fødende kvinder og nybagte fædre efter alder og tid. Gennemsnitsalder for førstegangsfødende kvinder og gennemsnitsalder for samtlige fødende kvinder fra 1960-2021. https://www.statistikbanken.dk/FOD11.
Lutjen, P. et al. The establishment and maintenance of pregnancy using in vitro fertilization and embryo donation in a patient with primary ovarian fail-ure. Nature 307, 174–175 (1984). DOI: https://doi.org/10.1038/307174a0
LOV nr 1688 af 26/12/2017: dobbelt-donation blev lovligt i Danmark. Lo-ven trådte i kraft den 1. januar 2018. Preprint at https://www.retsinformation.dk/eli/lta/2017/1688.
Blázquez, A., Vassena, R., Rodríguez, A., Figueras, F. & Vernaeve, V. Char-acteristics and clinical outcomes of pa-tients undergoing fertility treatment by double gamete donation. Hum Fertil 19, 180–185 (2016). DOI: https://doi.org/10.1080/14647273.2016.1209577
Rizzello, F. et al. Comorbidities, risk factors and maternal/perinatal out-comes in oocyte donation pregnancies. Reprod Biomed Online 41, 309–315 (2020). DOI: https://doi.org/10.1016/j.rbmo.2020.04.020
Storgaard, M. et al. Obstetric and neo-natal complications in pregnancies conceived after oocyte donation: a sys-tematic review and meta-analysis. BJOG 124, 561–572 (2017). DOI: https://doi.org/10.1111/1471-0528.14257
Blázquez, A. et al. Is oocyte donation a risk factor for preeclampsia? A sys-tematic review and meta-analysis. J Assist Reprod Genet 33, 855–863 (2016). DOI: https://doi.org/10.1007/s10815-016-0701-9
Berntsen, S., Larsen, E. C., la Cour Freiesleben, N. & Pinborg, A. Preg-nancy outcomes following oocyte do-nation. Best Practice and Research: Clinical Obstetrics and Gynaecology vol. 70 81–91 Preprint at https://doi.org/10.1016/j.bpobgyn.2020.07.008 (2021). DOI: https://doi.org/10.1016/j.bpobgyn.2020.07.008
González-Comadran, M. et al. The impact of donor insemination on the risk of preeclampsia: A systematic re-view and meta-analysis. European Journal of Obstetrics and Gynecology and Reproductive Biology vol. 182 160–166 Preprint at https://doi.org/10.1016/j.ejogrb.2014.09.022 (2014). DOI: https://doi.org/10.1016/j.ejogrb.2014.09.022
Kyrou, D., Kolibianakis, E. M., Devro-ey, P. & Fatemi, H. M. Is the use of donor sperm associated with a higher incidence of preeclampsia in women who achieve pregnancy after intrauter-ine insemination? Fertil Steril 93, 1124–1127 (2010). DOI: https://doi.org/10.1016/j.fertnstert.2008.12.021
Tenório, M. B. et al. Cross-Talk be-tween Oxidative Stress and Inflamma-tion in Preeclampsia. Oxid Med Cell Longev 2019, 1–26 (2019). DOI: https://doi.org/10.1155/2019/8238727
Phipps, E., Prasanna, D., Brima, W. & Jim, B. Preeclampsia: Updates in Pathogenesis, Definitions, and Guide-lines. Clinical Journal of the American Society of Nephrology 11, 1102–1113 (2016). DOI: https://doi.org/10.2215/CJN.12081115
van Bentem, K. et al. The development of preeclampsia in oocyte donation pregnancies is related to the number of fetal-maternal HLA class II mismatch-es. J Reprod Immunol 137, 103074 (2020). DOI: https://doi.org/10.1016/j.jri.2019.103074
Hiby, S. E. et al. Combinations of Ma-ternal KIR and Fetal HLA-C Genes In-fluence the Risk of Preeclampsia and Reproductive Success. Journal of Ex-perimental Medicine 200, 957–965 (2004). DOI: https://doi.org/10.1084/jem.20041214
Saftlas, A. F. et al. Cumulative expo-sure to paternal seminal fluid prior to conception and subsequent risk of preeclampsia. J Reprod Immunol 101–102, 104–110 (2014). DOI: https://doi.org/10.1016/j.jri.2013.07.006
Blazquez, A., García, D., Vassena, R., Figueras, F. & Rodriguez, A. Risk of preeclampsia in pregnancies resulting from double gamete donation and from oocyte donation alone. Pregnancy Hy-pertens 13, 133–137 (2018). DOI: https://doi.org/10.1016/j.preghy.2018.06.010
Preaubert, L. et al. Outcomes of preg-nancies achieved by double gamete donation: A comparison with pregnan-cies obtained by oocyte donation alone. European Journal of Obstetrics and Gynecology and Reproductive Bi-ology 222, 1–6 (2018). DOI: https://doi.org/10.1016/j.ejogrb.2017.12.026
Kelkar, R. L., Meherji, P. K., Kadam, S. S., Gupta, S. K. & Nandedkar, T. D. Circulating auto-antibodies against the zona pellucida and thyroid microsomal antigen in women with premature ovarian failure. J Reprod Immunol 66, 53–67 (2005). DOI: https://doi.org/10.1016/j.jri.2005.02.003
Malchau, S. S. et al. Perinatal out-comes in 375 children born after oo-cyte donation: a Danish national co-hort study. Fertil Steril 99, 1637-1643.e3 (2013).
Moussa, H. N., Arian, S. E. & Sibai, B. M. Management of Hypertensive Dis-orders in Pregnancy. Women’s Health 10, 385–404 (2014). DOI: https://doi.org/10.2217/WHE.14.32
Rana, S., Lemoine, E., Granger, J. P. & Karumanchi, S. A. Preeclampsia. Circ Res 124, 1094–1112 (2019). DOI: https://doi.org/10.1161/CIRCRESAHA.118.313276
Khader, Y. S., Batieha, A., Al-njadat, R. A. & Hijazi, S. S. Preeclampsia in Jordan: incidence, risk factors, and its associated maternal and neonatal out-comes. The Journal of Maternal-Fetal & Neonatal Medicine 31, 770–776 (2018). DOI: https://doi.org/10.1080/14767058.2017.1297411
Pereira, M. M., Mainigi, M. & Strauss, J. F. Secretory products of the corpus luteum and preeclampsia. Hum Reprod Update 27, 651–672 (2021). DOI: https://doi.org/10.1093/humupd/dmab003
Ginström Ernstad, E., Wennerholm, U.-B., Khatibi, A., Petzold, M. & Bergh, C. Neonatal and maternal out-come after frozen embryo transfer: In-creased risks in programmed cycles. Am J Obstet Gynecol 221, 126.e1-126.e18 (2019). DOI: https://doi.org/10.1016/j.ajog.2019.03.010
DSOG. Hypertension og præeklampsi. Obstetrisk Guideline. (2018).
Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 183, s1–s22 (2000). DOI: https://doi.org/10.1067/mob.2000.107928
Woudstra, D. M., Chandra, S., Hof-meyr, G. J. & Dowswell, T. Cortico-steroids for HELLP (hemolysis, ele-vated liver enzymes, low platelets) syndrome in pregnancy. Cochrane Da-tabase of Systematic Reviews (2010) doi:10.1002/14651858.CD008148.pub2. DOI: https://doi.org/10.1002/14651858.CD008148.pub2
International Association of Diabetes and Pregnancy Study Groups Recom-mendations on the Diagnosis and Clas-sification of Hyperglycemia in Preg-nancy. Diabetes Care 33, 676–682 (2010). DOI: https://doi.org/10.2337/dc09-1848
Blencowe, H. et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected coun-tries: a systematic analysis and impli-cations. The Lancet 379, 2162–2172 (2012). DOI: https://doi.org/10.1016/S0140-6736(12)60820-4
Savchev, S. et al. Estimated weight centile as a predictor of perinatal out-come in small-for-gestational-age pregnancies with normal fetal and ma-ternal Doppler indices. Ultrasound in Obstetrics & Gynecology 39, 299–303 (2012). DOI: https://doi.org/10.1002/uog.10150
Apgar, V. The Newborn (APGAR) Scoring System: Reflections and Ad-vice. Pediatr Clin North Am 13, 645–650 (1966). DOI: https://doi.org/10.1016/S0031-3955(16)31874-0
DSOG Obstetriske guidelines. Intra-partal acidose – asfyksi 2010.
World Health Organization. The Sur-veillance of Risk Factors Report Series (SuRF). (2005).
Malchau, S. S. et al. Perinatal out-comes in 375 children born after oo-cyte donation: a Danish national co-hort study. Fertil Steril 99, 1637-1643.e3 (2013). DOI: https://doi.org/10.1016/j.fertnstert.2013.01.128
DSOG. Præeklampsi og Hypertension. Obstetrisk Guideline 2018. Preprint at (2018).
Gestationel diabetes mellitus: Scree-ning og diagnose. DSOG obstetrisk guideline 2014.
Dansk Kvalitetsdatabase for Fødsler (DKF). Årsrapport. (2021).
Augusto, J. & Margarida Póvoa, A. Preeclampsia risk in oocyte donation versus double gamete donation preg-nancies: A systematic review and me-ta-analysis. European Journal of Ob-stetrics & Gynecology and Reproduc-tive Biology 276, 219–227 (2022). DOI: https://doi.org/10.1016/j.ejogrb.2022.07.025
Maheshwari, A., Pandey, S., Shetty, A., Hamilton, M. & Bhattacharya, S. Obstetric and perinatal outcomes in singleton pregnancies resulting from the transfer of frozen thawed versus fresh embryos generated through in vitro fertilization treatment: a sys-tematic review and meta-analysis. Fer-til Steril 98, 368-377.e9 (2012). DOI: https://doi.org/10.1016/j.fertnstert.2012.05.019
Maheshwari, A. et al. Is frozen embryo transfer better for mothers and babies? Can cumulative meta-analysis provide a definitive answer? Hum Reprod Up-date 24, 35–58 (2018). DOI: https://doi.org/10.1093/humupd/dmx031
Barsky, M., st. Marie, P., Rahil, T., Markenson, G. R. & Sites, C. K. Are perinatal outcomes affected by blasto-cyst vitrification and warming? Am J Obstet Gynecol 215, 603.e1-603.e5 (2016). DOI: https://doi.org/10.1016/j.ajog.2016.06.002
Chen, Z.-J. et al. Fresh versus Frozen Embryos for Infertility in the Polycys-tic Ovary Syndrome. New England Journal of Medicine 375, 523–533 (2016). DOI: https://doi.org/10.1056/NEJMoa1513873
von Versen-Höynck, F. et al. Increased Preeclampsia Risk and Reduced Aortic Compliance With In Vitro Fertilization Cycles in the Absence of a Corpus Lu-teum. Hypertension 73, 640–649 (2019). DOI: https://doi.org/10.1161/HYPERTENSIONAHA.118.12043
Roberge, S., Bujold, E. & Nicolaides, K. H. Aspirin for the prevention of preterm and term preeclampsia: sys-tematic review and metaanalysis. Am J Obstet Gynecol 218, 287-293.e1 (2018). DOI: https://doi.org/10.1016/j.ajog.2017.11.561
Wright, D. et al. Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit. Am J Obstet Gynecol 218, 612.e1-612.e6 (2018). DOI: https://doi.org/10.1016/j.ajog.2018.02.014